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We have shown that non-pathogenic enteric Gram-
negative Bacteroides vulgatus induces RelA phosphoryl-
ation, NF-B activation, and proinflammatory gene ex-
pression in primary and intestinal epithelial cell (IEC)
lines. We now demonstrate the transient induction of
nuclear phospho-RelA (day 3) followed by persistent ac-
tivation of phospho-Smad2 (days 3 and 7) in IEC from
mucosal tissue sections of B. vulgatus-monoassociated
rats, indicating that both NF-B and transforming
growth factor-1 (TGF-1) signaling are induced in vivo
following bacterial colonization. Interestingly, TGF-1
inhibited B. vulgatus- and lipopolysaccharide (LPS)-
induced NF-B transcriptional activity as well as in-
terleukin-6 (IL-6) mRNA accumulation and protein se-
cretion in IEC. The inhibitory effect of TGF-1 is
mediated independently of B. vulgatus/LPS-induced
IB, Akt, and RelA phosphorylation as well as NF-B
DNA binding activity. Moreover, the specific histone
deacetylase inhibitor trichostatin A blocked B. vulga-
tus/LPS-induced histone acetylation/phosphorylation
(Lys-9/Ser-10) and reversed TGF-1-mediated inhibi-
tion of IL-6 gene expression. Chromatin immunopre-
cipitation analysis revealed that B. vulgatus/LPS-
induced RelA recruitment to the IL-6 promoter is
inhibited by TGF-1 treatment. Adenoviral delivery of
Smad7 and dominant negative Smad3 (Smad3) re-
versed the TGF-1-mediated inhibition of NF-B tran-
scriptional activity and NF-B recruitment to the IL-6
promoter. In addition, TGF-1 and Ad5Smad3/4 pre-
vent B. vulgatus/LPS-induced CBP/p300 and p65 nu-
clear co-association. We concluded that the TGF-1/
Smad signaling pathway helps maintain normal
intestinal homeostasis to commensal luminal enteric
bacteria by regulating NF-B signaling in IEC through
altered histone acetylation.
Various enteroinvasive and pathogenic bacteria induce a
complex profile of proinflammatory genes in intestinal epithe-
lial cells (IEC)1 by activating multiple signaling cascades, in-
cluding the transcription factor NF-B (1, 2). More recently, we
have shown that the non-pathogenic commensal enteric bacte-
rial species Bacteroides vulgatus activates ICAM-1 gene ex-
pression through a mechanism involving both NF-B nuclear
translocation and RelA phosphorylation in primary and IEC
lines (3). These data suggest that non-pathogenic commensal
as well as pathogenic bacteria have the potential to initiate
innate host responses in IEC. The key role for commensal
luminal bacteria in the pathogenesis of inflammatory bowel
disease (IBD) is supported by the compelling evidence that
intestinal inflammation is dramatically reduced or absent in
germ-free rodent models susceptible for the development of
chronic experimental colitis (4–7). In addition, reconstitution
studies of gnotobiotic HLA-B27 transgenic rats (8, 9) and car-
rageenan-induced colitis in guinea pigs (10) suggest that se-
lected bacterial species such as B. vulgatus are particularly
important to the induction of colitis in these models. Of note,
these bacteria induced no colitis in wild type rats, documenting
their non-pathogenic nature (8, 9). We hypothesize that com-
mensal non-pathogenic bacteria-induced NF-B transcrip-
tional activity and gene expression is regulated by a complex
network of anti-inflammatory molecules and regulatory im-
mune cells that prevents chronic intestinal inflammation in a
normal host. Understanding the molecular mechanisms of IEC
hyporesponsiveness to constant bacterial exposure would re-
veal important regulatory elements involved in the mainte-
nance of intestinal homeostasis.
IEC must adapt to a constant and constitutively changing
luminal environment by processing different biological infor-
mation through multiple signaling cascades that target a de-
fined set of genes, which then provide an adequate effector
response (2). Importantly, these extracellular cytoplasmic sig-
nals must be integrated with the action of various nuclear
signal processes controlling access of transcription factors to
the regulatory region of gene promoters. In the case of NF-B,
this implies induction of a signaling cascade that leads to the
release of the transcription factor from its cytoplasmic inhibitor
IB, shuttling of the transcription factor to the nucleus where
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it accumulates. Simultaneously, activation of nuclear signaling
proteins permits access to gene promoter regions (11). In the
resting state, transcriptionally inactive chromatin is tightly
wrapped around histone proteins that hinder DNA binding by
transcriptional factors, providing an additional complex layer
of gene regulation. Histone wrapping to DNA and consequently
accessibility of transcription factors to gene promoter elements
is regulated by post-translational modifying mechanisms, such
as histone acetylation, phosphorylation, and methylation. Sig-
naling cascades responsible for the activation of transcription
factors must act synchronously with the different pathways
leading to chromatin unfolding in order to achieve coordinate
gene expression. For example, signaling cascades that impact
the levels of histone acetylation strongly influence chromatin
remodeling and gene expression (11–13). The status of histone
acetylation is dictated by the opposite action of the two en-
zymes histone acetyltransferase (HAT), which catalyzes acety-
lation of lysine residues present at the N-terminal part of the
histone tail, and the histone deacetyltransferase (HDAC),
which removes acetyl groups. Indeed, NF-B binding to tran-
scriptional active chromatin is influenced by the status of his-
tone acetylation/phosphorylation (14–16). Whether the level of
histone acetylation impacts bacteria-induced NF-B-depend-
ent gene expression in IEC is currently unknown.
In vivo, the response of IEC to commensal bacteria is regu-
lated by adjacent lamina propria mononuclear cells, which
mediate immunologic tolerance and maintain mucosal homeo-
stasis (17). Among the anti-inflammatory molecules implicated
in the regulation of intestinal homeostasis, transforming
growth factor (TGF)-1 has been shown to play a key role in
controlling proliferation, differentiation, and function of nu-
merous immune and non-immune cells (18–20). The biological
effect of TGF-1 is mediated through activation of various
signaling cascades such as Smad and the mitogen-activated
protein kinases, the latter including extracellular signal-regu-
lated kinases, stress-activated protein kinases/c-Jun N-termi-
nal kinases, and the p38 pathway. Upon TGF-1 binding to the
receptor complex, the Smad signaling pathway is activated
through phosphorylation of the receptor activated Smad1–3
(R-Smads), which dissociate from the receptor complex and
associate with the common partner Smad4 (co-Smad4). Result-
ing heterodimers then translocate to the nucleus and directly
bind to Smad-binding elements on the DNA to induce target
gene transcription (21–24). Another important aspect of TGF-
signal transduction is the induction/activation of inhibitory
molecules such as Smad6 and Smad7, which act as negative
regulators of TGF-1/Smad signaling by interfering with either
the activation of R-Smads or the association of R-Smads with
Smad4 (25).
Although TGF-1 regulates the host immune response to
various micro-organisms and inflammatory mediators (26,
27), the molecular mechanisms remain to be elucidated. In
this study, we characterized TGF-1 signal transduction in
IEC and investigated its effect on bacteria-induced NF-B
signaling. We report that TGF-1-activated Smad signaling
mediates inhibition of B. vulgatus and LPS-induced NF-B
recruitment to the IL-6 gene promoter through modulation of
histone acetylation. Activation of this inhibitory pathway
may be important in down-regulating IEC responses to com-
mensal bacteria.
MATERIALS AND METHODS
Cell Culture and Bacterial Stimulation of IEC—The mouse IEC line
CMT93 (passage 10–30) (ATCC CRL 223, American Type Culture Col-
lection (ATCC), Manassas, VA) was grown to confluency in 12- or 6-well
plates (Nunc). B. vulgatus derived from a guinea pig with carrageenan-
induced colitis (a gift from Dr. A. B. Onderdonk, Harvard University,
Cambridge, MA) was anaerobically grown at 37 °C in brain-heart infu-
sion, and B. vulgatus lysates were prepared as described previously (3).
Confluent monolayers of IEC were stimulated with B. vulgatus (5  107
cfu/ml), B. vulgatus lysate (100 g of protein/ml), or LPS (10 g/ml; from
E. coli serotype O111:B4, Sigma). Where indicated IEC were treated
with TGF-1 (20 ng/ml, R & D Systems) and the specific histone
deacetylase (HDAC) inhibitor trichostatin A (TSA) (2 h pretreatment
with 1 g/ml, Sigma).
Immunohistochemistry and Isolation of Primary Intestinal Epithelial
Cells—Germ-free (sterile) Fisher F344 rats were monoassociated at
10–12 weeks of age with B. vulgatus and maintained in the Gnotobiotic
Animal Core at the College of Veterinary Medicine, North Carolina
State University, Raleigh. Bacterial monoassociation was confirmed by
anaerobic culture of stool samples. Rats were killed at day 3 and 7 after
initial bacterial colonization. Sections of the ileum, cecum, and proxi-
mal and distal colon were fixed in 10% neutral buffered formalin. The
fixed tissue was embedded in paraffin. Immunohistochemistry was
performed using anti-phospho-NF-B p65 (RelA), anti-phospho-Smad2,
anti-phospho-c-Jun, and anti-phospho-p38 Abs (Cell Signaling, Beverly,
MA) according to the protocol of the manufacturer, and sections were
counterstained with hematoxylin. Histology scoring was analyzed by
scoring the degree of lamina propria mononuclear cell infiltration, crypt
hyperplasia, goblet cell depletion, and architectural distortion as de-
scribed previously (8).
Adenoviral Infection—CMT93 cells were infected overnight with
Ad5B-LUC as described previously (3). Where indicated CMT93 were
co-infected for an additional 12 h with Ad5IBAA or Ad5Smad7 (a
generous gift from Dr. David A. Brenner, University of North Carolina,
Chapel Hill, NC) or Ad5Smad3C or Ad5Smad3/Ad5Smad4 (a generous
gift of Dr. X. F. Wang, Duke University, Durham, NC) at a multiplicity
of infection (m.o.i.) of 50. The Smad3C, Smad3, and Smad4 constructs
were described previously by Wu et al. (28) and Zhang et al. (29). The
Ad5GFP containing green fluorescent protein was used as a viral neg-
ative control. The adenoviruses were washed off, and fresh medium
containing serum was added. Cells were stimulated at various time
points with B. vulgatus (5  107 cfu/ml), B. vulgatus lysate (100 g/ml),
or LPS (10 g/ml).
Transfection and Reporter Gene Assay—CMT93 cells were trans-
fected with plasmid expressing 3TP-LUX (1 g, a generous gift of Dr.
Richard A. Rippe, University of North Carolina, Chapel Hill) using
LipofectAMINE Reagent (Invitrogen) as described previously (3). Cells
were then stimulated with TGF-1 (20 ng/ml) for 12 h. Cell extracts
were prepared using enhanced luciferase assay reagents (Analytical
Luminescence, San Diego). Luciferase assay were performed on a Mono-
light 2010 luminometer for 20 s (Analytical Luminescence, San Diego),
and results were normalized for extract protein concentrations meas-
ured with the Bio-Rad protein assay kit (Bio-Rad).
Chromatin Immunoprecipitation (ChIP) Analysis—CMT93 cells
were stimulated with LPS for 0–2 h. After stimulation, IEC were
washed in cold phosphate-buffered saline (1 time) and fixed by adding
formaldehyde to a final concentration of 1%. Nuclear extraction and
chromatin immunoprecipitation were performed as described previ-
ously (16). Cells were lysed after formaldehyde fixation in L1 lysis
buffer (50 mM Tris, pH 8.0, 2 mM EDTA, 0.1% Nonidet P-40, and 10%
glycerol) supplemented with protease inhibitors. Nuclei were pelleted
and resuspended in 300 l of L2 lysis buffer (50 mM Tris, pH 8.0, 0.1%
SDS, and 5 mM EDTA). Chromatin was sheared by sonication (4 times
for 15 s at about one-fifth of maximum power), centrifuged, and diluted
in dilution buffer (50 mM Tris, pH 8.0, 0.5% Nonidet P-40, 0.2 M NaCl,
and 0.5 mM EDTA). Extracts were normalized according to their DNA
concentration and were precleared for 3 h with salmon sperm-saturated
protein A/G-agarose. Immunoprecipitation were carried out overnight
at 4 °C using 10 l of anti-NF-B p65 Ab (Rockland, Gilbertsville, PA).
Immune complexes were collected with salmon sperm-saturated pro-
tein A/G-agarose for 30 min and washed three times in high salt buffer
(20 mM Tris, pH 8.0, 0.1% SDS, 0.5 M NaCl, 1% Nonidet P-40, 2 mM
EDTA) followed by three washes with no salt buffer (TE 1). Immune
complexes were extracted 3 times with 150 l of extraction buffer (1%
SDS, 0.1 M NaHCO2). DNA cross-links were reverted by heating for 8 h
at 65 °C. After proteinase K (100 g for 1 h) digestion, DNA was
extracted with phenol/chloroform and precipitated in ethanol. DNA
isolated from an aliquot of the total nuclear extract was used as a
loading control for the PCR (input control). PCR was performed with
total DNA (1 l, input control) and immunoprecipitated DNA (1 l)
using the following IL-6 promoter-specific primers: IL-6A (5) 5-GA-
CATGCTCAAGTGCTGAGTCAC-3 (position 987–1009) and IL-6B (3)
5-AGATTGCACAATGTGACGTCG-3 (position 1112–1132). The length
of the amplified product was 125 bp. The PCR products (10 l) were
subjected to electrophoresis on 2% agarose gels containing gel Star
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fluorescent dye (FMC, Philadelphia, PA). Fluorescent staining was
captured using an AlphaImager 2000 (AlphaInnotech, San Leandro,
CA).
In Vitro Kinase Assays—IKK activity on B. vulgatus-induced serine
RelA phosphorylation was determined by immunocomplex kinase assay
as described previously (3). Briefly, CMT93 cells were lysed in Triton
lysis buffer containing protease and phosphatase inhibitors after stim-
ulation with B. vulgatus/LPS at various times in the presence or ab-
sence of TGF-1. 300 g was immunoprecipitated with 2 l of anti-
IKK (Cell Signaling, Beverly, MA), and the kinase reaction was
performed by glutathione S-transferase (GST)-p65 (1–305 and 354–
551) (a generous gift of Dr. Hiroaki Sakurai, Tanabe Seiyaku, Osaka,
Japan) as substrate for 30 min at 30 °C. Substrate protein was resolved by
gel electrophoresis, and phosphate incorporation was assessed by audio-
radiography and PhosphorImager analysis (Amersham Biosciences).
RNA Extraction and Reverse Transcriptase-PCR Analysis—RNA was
isolated using Trizol (Invitrogen), and 1 g of total RNA was reverse-
transcribed and amplified (reverse transcriptase PCR) using specific
primers for mouse IL-6 and GAPDH as described previously (3). The
following oligonucleotide primers were used: IL-6-A, (5) 5-ATGAAGT-
TCCTCTCTGCAAGAGACT-3 (position 35–56), and IL-6-B, (3) 5-CAC-
TAGGTTTGCCGAGTAGATCTC-3 (position 646–669); GAPDH-A, (5)
5-CGGTGCTGAGTATGTCGTGGAGTCT-3 (position 310–334), and
GAPDH-B, (3) 5-GTTATTATGGGGGTCTGGGATGGAA-3 (position
1140–1164). The length of the amplified product was of 638 and 854 bp,
respectively.
Western Blot Analysis—CMT93 cells were stimulated for various
times (0–4 h) with B. vulgatus (5  107 cfu/ml), B. vulgatus lysate (100
g/ml), or LPS (10 g/ml). The cells were lysed in 1 Laemmli buffer,
and 20 g of protein was subjected to electrophoresis on 10% SDS-
polyacrylamide gels as described previously (3). Where indicated
CMT93 cells were pretreated for 1 h with 20 M of the proteasome
inhibitor MG132 (100 ng/ml, Biomol, Plymouth Meeting, PA). Anti-
phosphoserine Smad2 (Ser-465/467, Cell Signaling, Beverly, MA), anti-
phosphoserine Smad2/3 (Ser-433/435, Santa Cruz Biotechnology, Santa
Cruz, CA), anti-Smad4/DPC4 (Upstate Biotechnology, Lake Placid,
NY), anti-phosphoserine IB (S32, Cell Signaling, Beverly, MA), anti-
phosphoserine RelA (S536, Cell Signaling, Beverly, MA), anti-phospho-
serine Akt (S473, Cell Signaling, Beverly, MA), anti-acetyl and phos-
phohistone 3 (Lys-9/Ser-10, Cell Signaling, Beverly, MA), and anti--
actin (ICN, Costa Mesa, CA) were used to detect immunoreactive
phospho-Smad2, phospho-Smad2/3, Smad4/DPC, phospho-IB, phos-
pho-RelA, phospho-Akt, acetyl-phosphohistone 3, and -actin, respec-
tively, using enhanced chemiluminescence light detecting kit (Amer-
sham Biosciences).
Co-immunoprecipitation—CMT93 cells were stimulated with B. vul-
gatus/LPS for 30 min in the presence or absence of TGF-1. Where
indicated CMT-93 cells were co-infected with Ad5Smad3 and
Ad5Smad4. Nuclear extract were prepared as described above, and
protein concentration was normalized. Immunoprecipitation were car-
ried out overnight at 4 °C using 10 l of anti-NF-B p65 Ab (Rockland,
Gilbertsville, PA). Immune complexes were collected with protein A/G-
agarose for 30 min and washed 3 times in high salt buffer (20 mM Tris,
pH 8.0, 0.1% SDS, 0.5 M NaCl, 1% Nonidet P-40, 2 mM EDTA) followed
by three washes with no salt buffer (1 TE). The immune complexes were
cleaved from the beads by adding 50 l of 1 Laemmli buffer. Western
blot analysis was carried out using anti-CBP/p300 Ab (Upstate, Lake
Placid, NY) as described above.
Nuclear Extracts and Electrophoretic Mobility Shift Assay—CMT93
cells were stimulated for various times (0–4 h) with B. vulgatus lysate
(100 g/ml), and nuclear extracts were prepared as described previously
(3). Extracts (5 g) were incubated with radiolabeled double-stranded
class I major histocompatibility complex B sites (GGCTGGGGATTC-
CCCATCT), separated by nondenaturating electrophoresis, and ana-
lyzed by autoradiography as described previously (30).
ELISA—CMT93 cells were stimulated with B. vulgatus and LPS for
16–24 h. Murine IL-6 was determined in the cell culture supernatant
using ELISA (R & D Systems).
Statistical Analysis—Data are expressed as means  S.D. of tripli-
cate experiments. Statistical significance was performed by the two-
tailed Student’s t test for paired data and considered significant if p
values were 0.05 and 0.01.
RESULTS
B. vulgatus Monoassociated Rats Show Nuclear Localization
of Phospho-RelA and Phospho-Smad2 in IEC—We first sought
to demonstrate activation of NF-B and TGF- signaling in
vivo following B. vulgatus monoassociation of germ-free Fisher
F344 rats. Monoassociated rats were killed 3 and 7 days after
initial bacterial colonization, and sections of the ileum, cecum,
proximal and distal colon were analyzed by using immunohis-
tochemical analysis and histological scoring. Fig. 1A shows
nuclear localization of phospho-RelA (Ser-536) in cecal epithe-
lial cells 3 days after B. vulgatus monoassociation but not at
day 7 or in germ-free controls, suggesting transient NF-B
activation in intestinal epithelial cells after initial bacterial
colonization. Nuclear phospho-RelA staining was stronger in
the surface region of the cecal epithelium and almost absent in
the ileum, the proximal and distal colon, or in lamina propria
cells (Fig. 1B). None of the histologically examined sections
FIG. 1. A and B, nuclear localization of phospho-RelA in the
intestinal epithelium of B. vulgatus-monoassociated rats. Germ-
free Fisher F344 rats were monoassociated with B. vulgatus. Rats were
killed at days 3 and 7 (3d and 7d) after initial bacterial colonization.
Sections of the ileum, cecum, and proximal and distal cecum were fixed
in 10% neutral buffered formalin. Immunohistochemistry was per-
formed on paraffin-embedded tissue sections using anti-RelA antibody,
and sections were counterstained with hematoxylin. A, nuclear phos-
pho-RelA staining of cecal sections from germ-free and bacterial mono-
associated rats is shown at a magnification of 20. Isotype antibodies
are used as a control. B, nuclear phospho-RelA staining of sections from
ileum, cecum, and proximal and distal colon of B. vulgatus-monoasso-
ciated rats (3 days) is shown at a magnification of 40. Representative
sections of two different experiments are shown.
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revealed signs of pathologic inflammation.
Interestingly and in contrast to RelA, nuclear phospho-
Smad2 is sustained throughout days 3 and 7 after bacterial
monoassociation, with no signal detected in germ-free controls
(Fig. 2A). Nuclear phospho-Smad2 staining was first detected
in the lower crypt region of the cecal epithelium at day 3 but
was strongest in the surface region at day 7 after initial bac-
terial colonization of germ-free rats. Similar to the localization
of phospho-RelA, phospho-Smad2 was almost absent in the
ileum, the proximal and distal colon, or in lamina propria cells
(Fig. 2B). In addition, bacteria-induced RelA and Smad2 phos-
phorylation in primary large intestinal epithelial cells isolated
from B. vulgatus-monoassociated germ-free rats was confirmed
by Western blot analysis (Fig. 3A). We next sought to deter-
mine whether B. vulgatus induces RelA and Smad2 phospho-
rylation ex vivo in primary IEC isolated from germ-free rats.
Fig. 3B shows that B. vulgatus stimulation induces RelA but
not Smad2 phosphorylation, suggesting that bacteria-induced
Smad signaling is mediated by activation of TGF- production
by adjacent intestinal lamina propria mononuclear cells.
These data suggest different temporal and spatial phospho-
RelA and phospho-Smad2 distribution in B. vulgatus-monoas-
sociated rats and demonstrate that TGF-1 and NF-B signal-
ing pathways are activated in the intestine in vivo after non-
pathogenic bacterial colonization.
TGF-1 Activates the Smad Signal Transduction Pathway in
IEC Lines—Since B. vulgatus-monoassociated rats showed nu-
clear localization of phospho-Smad2 in IEC (Figs. 1 and 2), we
FIG. 2. A and B, nuclear localization of phospho-Smad2 in the
intestinal epithelium of B. vulgatus-monoassociated rats. Germ-
free Fisher F344 rats were monoassociated with B. vulgatus. Rats were
killed at day 3 and 7 (3d and 7d) after initial bacterial colonization.
Sections of the ileum, cecum, proximal and distal cecum were fixed in
10% neutral buffered formalin. Immunohistochemistry was performed
on paraffin-embedded tissue sections using anti-Smad2 antibody, and
sections were counterstained with hematoxylin. A, nuclear phospho-
Smad2 staining of cecal sections from germ-free and B. vulgatus-mono-
associated rats (days 3 and 7) is shown at a magnification of 20.
Isotype antibodies are used as a control. B, nuclear phospho-Smad2
staining of sections from ileum, cecum, and proximal and distal colon of
B. vulgatus-monoassociated rats (7 days) is shown at a magnification of
40. Representative sections of two different experiments are shown.
FIG. 3. A and B, B. vulgatus induces RelA but not Smad2 phos-
phorylation in isolated primary IEC. A, germ-free Fisher F344 rats
were monoassociated with B. vulgatus. Rats were killed at day 3 and 7
after initial bacterial colonization and primary IEC from the cecum and
colon were isolated. Total protein was extracted, and 20 g of protein
was subjected to SDS-PAGE followed by phospho-RelA, phospho-
Smad2, and -actin immunoblotting using the ECL technique. B, pri-
mary IEC from cecum and colon were isolated from germ-free Fisher
F344 rats. IEC were seeded into 6-well plates at a density of 2  106
cells per ml and stimulated with B. vulgatus (7  107 cfu/ml) for 0–4 h.
Total protein was extracted, and 20 g of protein was subjected to
SDS-PAGE followed by phospho-RelA, phospho-Smad2, and -actin
immunoblotting using the ECL technique.
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next sought to investigate TGF-1 signal transduction in IEC.
It is well established that TGF-1 activates the Smad signaling
pathway in numerous cell types (31); however, TGF-1 signal-
ing has not yet been investigated in IEC. TGF-1 induced rapid
(15 min) Smad2 phosphorylation in the colonic mouse epithe-
lial cell line CMT93, whereas the level of total unphosphoryl-
ated protein remained unaffected (Fig. 4A). We next investi-
gated whether phosphorylated Smad2/3 associates with co-
Smad4 in TGF-1-stimulated CMT93 cells. As shown by
immunoprecipitation analysis, phosphorylated Smad2 and
Smad3 (Fig. 4B, upper panel) rapidly associated with Smad4 in
TGF-1-stimulated CMT93 cells, but this association was tran-
sient with little evidence of complexing at 60 min. TGF-1-
activated Smad2 phosphorylation was confirmed in mouse pri-
mary IEC isolated from 129SvEv wild type mice (Fig. 4C).
These results suggest that TGF-1 induces the Smad signaling
cascade in primary and IEC lines. Finally, we investigated the
functional consequences of TGF-1-induced Smad activation in
CMT93 cells by using LipofectAMINE-based transfection of the
TGF--responsive reporter gene 3TP-LUX. Fig. 4D shows an
almost 4-fold increase in luciferase activity in TGF-1-stimu-
lated CMT93 cells.
TGF-1 Inhibits Non-pathogenic Gram-negative B. vulgatus
and LPS-induced NF-B Transcriptional Activity and IL-6
Gene Expression in IEC—B. vulgatus induces NF-B activity
and proinflammatory gene expression in IEC (3). Since TGF-1
has important immunosuppressive activity (20), we evaluated
its effect on B. vulgatus and LPS-mediated NF-B transcrip-
tional activation in IEC. We infected mouse CMT93 cells with
an adenoviral vector encoding for the (B)-luciferase reporter
gene (Ad5B-LUC) alone or in combination with the IB su-
per-repressor (Ad5IBAA) and then stimulated with B. vul-
gatus, B. vulgatus lysate, or LPS in the presence or absence of
TGF-1. As shown in Fig. 5A, TGF-1 significantly inhibited
B. vulgatus, B. vulgatus lysate, and LPS-induced NF-B tran-
scriptional activity in CMT93 cells (53, 40, and 47%, respec-
tively). In accordance with previous results (3), Ad5IBAA
almost completely blocked B. vulgatus, B. vulgatus lysate, and
LPS-induced NF-B transcriptional activity in CMT93 (70–
80% inhibition). Similar results were obtained in the rat small
intestinal epithelial cell line IEC-6 (data not shown). These
results demonstrate that TGF-1 significantly, but incom-
pletely, inhibits Gram-negative bacteria-induced NF-B tran-
scriptional activity in IEC.
Next, we evaluated whether TGF-1 inhibits the expression
of endogenous B-dependent genes. We stimulated CMT93
cells with B. vulgatus or LPS in the presence or absence of
TGF-1 and measured IL-6 mRNA expression as well as
protein secretion after 6 and 24 h, respectively. B. vulgatus
and LPS-induced IL-6 mRNA expression (Fig. 5B) and pro-
tein secretion (Fig. 5C) is significantly inhibited by TGF-1
treatment.
We have previously shown that B. vulgatus/LPS-induced
NF-B transcriptional activity requires IB and RelA phos-
phorylation as well as activation of phosphatidylinositol 3-ki-
nase/Akt pathway (3). Based on this finding, we first investi-
gated the effect of TGF-1 on B. vulgatus/LPS-induced NF-B
signal transduction by measuring endogenous IB, RelA, and
Akt phosphorylation as well as NF-B DNA-binding in CMT93
cells. Interestingly, TGF-1 did not alter B. vulgatus/LPS-in-
duced IB, RelA, and Akt phosphorylation (Fig. 6A) nor
NF-B DNA binding (Fig. 6C). Moreover, B. vulgatus/LPS-
induced RelA nuclear translocation as determined by immuno-
fluorescence was not inhibited by TGF-1 treatment (data
not shown).
B. vulgatus induces RelA phosphorylation in IEC at both
serine residues 536 and 529 (3). Since our antibody selectively
recognizes phosphorylated serine 536, we next used an in vitro
kinase assay to ascertain the effect of TGF-1 on bacteria-
induced RelA phosphorylation. We immunoprecipitated IKK
and performed a kinase assay using a GST fusion protein
containing the p65 transactivating domain (p65TAD; amino
acids 354–551) as described previously (3). Fig. 6B demon-
strates that GST-p65TAD (354–551) is phosphorylated in LPS
stimulated CMT93 cells with a kinetic pattern similar to en-
dogenous RelA Ser-536 phosphorylation (Fig. 6A). TGF-1
treatment did not affect LPS stimulated GST-p65TAD (354–
551) phosphorylation, suggesting that the inhibitory effect of
this cytokine operates independently of signal-induced proxi-
mal NF-B signaling.
FIG. 4. A–D, TGF-1 activates the Smad signal transduction
pathway in primary colonic and IEC lines. A, CMT-93 cells were
incubated with TGF-1 (20 ng/ml) for 15 min to 1 h. Total protein was
extracted, and 20 g of protein was subjected to SDS-PAGE followed by
phospho-Smad2 and Smad2 immunoblotting using the ECL technique.
B, CMT93 cells were stimulated with TGF-1 (20 ng/ml) for 30 min and
1 h. 300 g of protein were immunoprecipitated using anti-Smad4 Ab.
Western blot analysis was performed by subjecting 20 g of immuno-
precipitated protein to SDS-PAGE followed by phospho-Smad2/3 and
Smad4 immunoblotting using the ECL technique. C, primary IEC were
isolated from 129SvEv wild type mice as described under “Materials
and Methods.” Primary cells were stimulated for 30 min with TGF-1
(20 ng/ml) or medium alone. Total protein was extracted, and 20 g was
subjected to SDS-PAGE followed by phospho-Smad2 and -actin immu-
noblotting using the ECL technique. D, CMT93 cells were transfected
with 3TP-LUX reporter gene (1 g) and stimulated with TGF-1 or
medium alone for 12 h. Cell extracts and the luciferase assay were
performed as described under “Materials and Methods,” and results
were normalized for extract protein concentrations. These results are
representative of two independent experiments.
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Ad5Smad7 and AdSmad3 Reverse the Inhibitory Effect of
TGF-1 on Bacteria-induced NF-B Transcriptional Activity—
Proximal TGF-1 signal transduction has been shown to be
down-regulated by the endogenous inhibitor Smad7 (31). To
study the functional role of TGF-1/Smad in blocking B. vul-
gatus-induced NF-B transcriptional activity, we used an ad-
enoviral vector to deliver biologically active Smad7 (Ad5S-
mad7). Initially, CMT93 cells were infected with Ad5B-LUC
in combination with Ad5Smad7 and then stimulated with B.
vulgatus or LPS. Interestingly, TGF-1-mediated inhibition of
B. vulgatus- (Fig. 7A) and LPS-induced (Fig. 7B) NF-B tran-
scriptional activity was completely reversed in Ad5Smad7- but
not Ad5GFP-infected cells. Infection of CMT93 cells with
Ad5Smad7 was confirmed by Western blot analysis using anti-
Smad7 and anti-HA Abs (Fig. 7A).
To document further the involvement of Smad signaling in
TGF-induced inhibitory effect on NF-B transcriptional activ-
ity, we used a dominant negative Smad3 (Ad5Smad3). Simi-
larly to Smad7, TGF-1-induced suppression of B. vulgatus-
and LPS-induced NF-B transcriptional activity is inhibited in
Ad5Smad3-infected CMT-93 cells (Fig. 7, C and D). Infection
of CMT93 cells with Ad5Smad3 was confirmed by Western
blot analysis using anti-HA Abs (Fig. 7C).
TGF-1 Inhibits Histone 3 Acetylation/Phosphorylation and
Bacteria-induced Recruitment of RelA to the IL-6 Promoter—
Previous reports (14–16) have demonstrated that changes in
histone acetylation/phosphorylation strongly influence recruit-
ment of NF-B to selected target genes. Because TGF-1-me-
diated inhibition of IL-6 gene expression occurs independently
of the classical NF-B signal transduction, we next investi-
gated the effect of this immunosuppressive cytokine on histone
acetylation levels. We first used the specific histone deacety-
lase inhibitor TSA to determine whether the inhibitory effect of
TGF-1 is dependent of the status of histone acetylation. In-
terestingly, B. vulgatus- and LPS-induced histone 3 acetyla-
tion/phosphorylation (Lys-9/Ser-10) is inhibited in TGF-1-
treated cells (Fig. 8A, top and middle panels) but reversed in
the presence of TSA (Fig. 8A, lower panels). Moreover, TGF-
1-mediated inhibition of LPS-induced IL-6 secretion was re-
versed in TSA-treated cells (Fig. 8B). This suggests that TGF-
1-mediated inhibition of IL-6 gene expression involved
changes in histone acetylation.
To address specifically the effect of TGF-1-mediated repres-
sion of B. vulgatus/LPS-induced IL-6 gene expression, we per-
formed ChIP using a p65 antibody. CMT93 cells were stimu-
lated with LPS in the presence or absence of TGF-1, and p65
recruitment to the IL-6 promoter region was determined by
PCR. Fig. 8C shows that LPS strongly induced p65 recruitment
to the IL-6 promoter at 2 h (Fig. 8C, upper panel), which was
blocked by TGF-1 treatment (Fig. 8C, upper panel). Similar
levels of IL-6 were amplified from the total pool of genomic
DNA (input control), documenting that equal amounts were
used for the ChIP analysis (Fig. 8C, lower panel). To address
the role of Smad signaling on TGF-1-mediated inhibition of
IL-6 gene expression, we next used Ad5Smad7 or Ad5GFP-
infected cells for ChIP analysis. Ad5Smad7 but not Ad5GFP
reversed TGF-1-mediated inhibition of NF-B recruitment to
the IL-6 gene promoter (Fig. 8D). This suggests that TGF-1-
induced Smad signaling is necessary for inhibition of B. vulga-
tus/LPS-induced RelA recruitment to the IL-6 promoter in IEC.
TGF-1 Inhibits B. vulgatus-induced CBP/p300 and RelA
Nuclear Co-association—Since the nuclear co-activator CBP/
ELISA. The bars represent the combined mean values (S.D.) of trip-
licate experiments from two different experiments. N.D., not
determined.
FIG. 5. A–C, TGF-1-mediated inhibition of B. vulgatus-in-
duced NF-B transcriptional activity and IL-6 gene expression
in IEC. A, CMT93 cells were infected with Ad5B-LUC (5 m.o.i.) for
12 h. Cells were washed and co-infected for additional 12 h with
Ad5IBAA. Finally, IEC were stimulated with B. vulgatus (5  107
cfu/ml), B. vulgatus lysate (100 g total protein/ml), LPS (10 g/ml), or
medium alone for additional 12 h in the presence or absence of TGF-1
(20 ng/ml). Cell extracts and the luciferase assay were performed as
described under “Materials and Methods,” and results were normalized
for extract protein concentrations. B, CMT93 cells were stimulated with
B. vulgatus lysate and LPS for 6 h in the presence or absence of TGF-1
(20 ng/ml). Total RNA was extracted, reverse-transcribed, and ampli-
fied using specific IL-6 and GAPDH primers. PCR products were run on
a 2% agarose gel and stained with gel star. These results are represent-
ative of two independent experiments. C, CMT93 cells were stimulated
with B. vulgatus lysate and LPS, and IL-6 protein secretion was meas-
ured in the cell culture supernatants after 24 h of stimulation by
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p300 has intrinsic HAT activity and associates with NF-B to
induce transcription (32, 33), we next investigated the effect of
TGF-1 or Ad5Smad3 and Ad5Smad4 on p65 and CBP/p300
association. Cells were treated with TGF-1 or Ad5Smad3/
Ad5Smad4 and then stimulated with LPS. Interestingly, co-
immunoprecipitation experiment demonstrates that TGF-1
treatment reversed LPS-induced nuclear CBP/p300 association
with p65 (Fig. 9, compare lanes 2 with 4). Moreover, the pres-
ence of Ad5Smad3/Ad5Smad4 also reversed LPS-induced CBP/
p300 association with p65 (Fig. 9, compare lanes 2 and 5),
suggesting that TGF-1-induced Smad signaling may prevent
bacteria-induced p65-CBP/p300 interaction in IEC.
In conclusion, these results suggest that B. vulgatus/LPS-
induced IL-6 gene expression in IEC is partially regulated by
TGF-1 through decreased histone acetylation/phosphoryla-
tion and loading of NF-B to the gene promoter.
DISCUSSION
Numerous reports point to a critical immunoregulatory func-
tion of TGF-1 in the maintenance of intestinal homeostasis.
First, Yang et al. (34) showed that targeted disruption of the
Smad3 gene caused massive T cell infiltration and pyogenic
abscess formation in the stomach and intestine. Subsequently,
Monteleone et al. (35) showed that Smad7, the endogenous
inhibitor of the Smad signal transduction pathway, is overex-
pressed in mucosal T cells from patients with IBD. In vitro
blocking of Smad7 restored TGF-1-mediated Smad phospho-
rylation and enhanced TGF-1-mediated inhibition of inflam-
matory cytokine production in lamina propria mononuclear
cells isolated from IBD patients. Moreover, TGF-1-deficient
mice spontaneously develop colitis (36), and overexpression of
TGF-1 in lamina propria immune cells inhibited Th1-medi-
ated experimental 2,4,6-trinitrobenzene sulfonic acid-induced
colitis (37, 38). The absence of colitis and pathogenic immune
responses to commensal enteric bacteria suggests that normal
hosts have well developed immunosuppressive mechanisms of
their mucosal immune systems.
Although the immunosuppressive effect of TGF-1 is well
established, the molecular mechanisms responsible for the im-
munomodulation remain to be elucidated. We now demonstrate
that TGF-1/Smad signaling inhibits B. vulgatus and LPS-
induced IL-6 gene expression through reduction of histone
acetylation/phosphorylation and decreased recruitment of
NF-B to the IL-6 promoter. First, we show for the first time a
sequential increase of nuclear RelA (day 3) and Smad2 (days 3
and 7) phosphorylation in cecal epithelial cells of B. vulgatus-
monoassociated germ-free Fisher F344 rats, suggesting that
this commensal bacterial strain induced both pro-inflamma-
tory and immunosuppressive signaling pathways in the host in
vivo. Second, by using primary and colonic cell lines, we provide
evidence that TGF-1 induced Smad2 phosphorylation, associ-
ation of phospho-Smad2/Smad3 with Smad4, and enhanced
TGF-1-dependent transcriptional activity, suggesting a func-
tional TGF-1-mediated Smad signal transduction in IEC.
Third, we show that TGF-1 significantly inhibits B. vulgatus
and LPS-induced NF-B transcriptional activity as well as IL-6
gene expression in IEC, demonstrating the biological signifi-
cance of TGF-1 signal transduction in regulating IEC respon-
siveness to luminal Gram-negative bacteria and bacterial
products.
We have shown previously that B. vulgatus-induced NF-B
activation and pro-inflammatory gene expression require en-
LPS (10 g/ml) for 2 h in the presence or absence of TGF-1 (20 ng/ml).
NF-B DNA-binding activity was determined using electrophoretic mo-
bility shift assay. These results are representative of two independent
experiments.
FIG. 6. A–C, role of TGF-1 on B. vulgatus-induced NF-B sig-
naling cascade. A, CMT93 cells were stimulated with B. vulgatus
lysate (100 g of protein/ml) for 0–2 h in the presence or absence of
TGF-1 (20 ng/ml). Where indicated CMT93 cells were pretreated with
20 M MG132. Total protein was extracted, and 20 g of protein was
subjected to SDS-PAGE followed by phospho-IB, RelA, and Akt im-
munoblotting using the ECL technique. B, LPS-induced serine RelA
phosphorylation in the presence or absence of TGF-1 (20 ng/ml) was
determined by an immunocomplex kinase assay as described under
“Materials and Methods.” The kinase reaction was performed by incu-
bating 25 l of kinase buffer with either glutathione S-transferase
GST-p65 (residues 354–551) as substrate for 30 min at 30 °C. Substrate
protein was resolved by gel electrophoresis, and phosphate incorpora-
tion was assessed by audioradiography and PhosphorImager analysis.
Coomassie Blue staining shows equal loading (lower blot). C, CMT93
cells were stimulated with B. vulgatus lysate (100 g of protein/ml) or
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hanced phosphatidylinositol 3-kinase/Akt and RelA phospho-
rylation (3). However, TGF-1 did not affect B. vulgatus-in-
duced IB, RelA, and Akt phosphorylation nor alter NF-B
DNA-binding, suggesting an alternative mechanism for the
TGF-1-mediated inhibition of B. vulgatus-induced NF-B
transcriptional activity in IEC. Of interest, levels of histone
acetylation/phosphorylation directly impact expression of some
NF-B-dependent genes by controlling access of the transcrip-
tion to the appropriate gene promoter (39). In addition, recent
studies (40, 41) demonstrate that TGF-/Smad-mediated tran-
scriptional repression involves recruitment of HDAC. Interest-
ingly, we demonstrate that the HDAC inhibitor TSA reversed
the TGF-1-mediated inhibitory effect on B. vulgatus/LPS-in-
duced IL-6 gene expression, suggesting that TGF-1 modulates
the status of histone acetylation. More directly, we show that
B. vulgatus/LPS-induced histone acetylation/phosphorylation
is inhibited by TGF-1 treatment. Similarly, we show that
loading of NF-B to the IL-6 promoter is inhibited by TGF-1
treatment in IEC. Together, these data point to a new regula-
tory mechanism of TGF-1-mediated immunosuppression
which involves decreased histone acetylation and inhibition of
NF-B accession to the gene promoter.
The mechanisms controlling the coordinated nuclear migra-
tion of transcription factors and access to various gene promot-
ers are not elucidated. Recently, activation of the mitogen-
activated protein kinase p38 was shown to be critical in LPS-
mediated histone phosphorylation and NF-B access to select
gene promoters in dendritic cells (16). Interestingly, we failed
to observe enhanced p38 phosphorylation in B. vulgatus- or
LPS-stimulated CMT93 cells.2 Although a role for p38 in bac-
teria and LPS-induced histone acetylation/phosphorylation
could not be totally ruled out, our data suggest that other
pathways may participate in histone modification, at least
in IEC.
The precise mechanism of enhanced NF-B transcriptional
activity by signal-induced RelA phosphorylation is not clearly
established. Zhong et al. (32, 33) have shown that LPS-induced
RelA serine 276 phosphorylation loosens its interaction with
HDAC and promotes its binding to the transcriptional co-acti-
vator CBP/p300 containing HAT activity. Interestingly, associ-
ation of HDAC1 and HDAC2 with unphosphorylated nuclear
RelA is associated with transcriptionally inactive NF-B (42).
However, we found no correlation between TGF1-mediated
inhibition of RelA recruitment to the IL-6 gene promoter and
the level of RelA phosphorylation. This was confirmed by in-
vestigating both endogenous serine 536 phosphorylation levels
by Western blot and by an in vitro kinase assay using a GST-
RelA substrate (serine 526 and 529). Since LPS-induced serine
276 phosphorylation strongly modulates NF-B transcriptional
activity (32, 33), the possibility remains that TGF-1 interferes
with this phosphorylation site and prevents bacteria-induced
NF-B transcriptional activity. However, RelA serine 276 phos-
2 D. Haller and C. Jobin, personal communication.
LUC (5 m.o.i.) for 12 h. Cells were washed and co-infected with
Ad5Smad7 (A and B, 50 m.o.i.), Ad5Smad3 (C and D, 50 m.o.i.), or
Ad5GFP (50 m.o.i.) for an additional 12 h. CMT93 cells were then
stimulated with B. vulgatus lysate (100 g of total protein/ml), LPS (10
g/ml), or medium alone for an additional 12 h in the absence or
presence of TGF-1. Expression of HA-tagged Smad3 (C–D) or Smad7
(A–B) protein of representative experiments is shown in the upper
panel. Cell extracts and the luciferase assay were performed as de-
scribed under “Materials and Methods,” and results were normalized
for extract protein concentrations. B. vulgatus/LPS-induced luciferase
activity is expressed as fold increase over control determined as the
mean of triplicate experiments. These results are representative of two
independent experiments.
FIG. 7. A–D, TGF-1-mediated inhibition of B. vulgatus/LPS-
induced NF-B transcriptional activity was reversed by
Ad5Smad7 and Ad5Smad3. CMT93 cells were infected with Ad5B-
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phorylation is not induced in B. vulgatus- and LPS-stimulated
IEC (3), suggesting that the TGF-1-mediated inhibition oper-
ates independently of the RelA phosphorylation status. There-
fore, although we observed a decrease in RelA phosphorylation
(day 7) but enhanced Smad phosphorylation (days 3–7) in
B. vulgatus monoassociated rats, these two events are likely
independent of each other. Decreased RelA phosphorylation
may represent an intrinsic down-regulatory mechanism pres-
ent in IEC.
B. vulgatus signaling to RelA phosphorylation and NF-B
DNA binding activity is intact in TGF1-treated cells, but RelA
recruitment to the IL-6 promoter is blocked. This suggests that
the immunoregulatory cytokine interferes with the activity of a
co-repressor or co-activator of NF-B. Interestingly, TGF-1-
mediated Smad signal transduction is necessary for inhibition
of B. vulgatus/LPS-induced NF-B transcriptional activity and
IL-6 gene expression, as demonstrated by reversed suppression
in Ad5Smad7 as well as in Ad5Smad3-infected cells. Of note,
TGF-induced nuclear Smad complex associates with the CBP/
p300 transcriptional co-activator (43–45). Interestingly, we
show that TGF-1 and the presence of Ad5Smad3/Ad5Smad4
reversed LPS-induced CBP/p300 p65 nuclear interaction. This
suggests that the mechanism of TGF--induced inhibitory ef-
fect involved decreased p65-CBP/p300 association, possibly
through negative titration by Smad proteins. Therefore, dimin-
ished CBP/p300 association with p65 in conjunction with de-
creased HAT activity could lead to impaired histone acetyla-
tion/phosphorylation and/or lower p65 recruitment to the IL-6
gene promoter. The formal interaction of Smad protein with
CBP/p300 and the precise role of this co-activator in bacteria
signaling in IEC will necessitate further investigation.
In conclusion, we demonstrate that TGF-1 inhibits non-
protein was measured in the cell culture supernatant by ELISA. Bars
represent the combined mean values ( S.D.) of triplicates from two
independent experiments. C and D, CMT93 cells were stimulated with
LPS (10 g/ml) for 0–2 h in the presence or absence of TGF-1 (20
ng/ml). Where indicated CMT-93 cells were infected with Ad5Smad7
(50 m.o.i.) or Ad5GFP (50 m.o.i.). ChIP analysis was performed as
described under “Materials and Methods.” Anti-RelA Ab was used to
immunoprecipitate equal amounts of DNA (input DNA). PCR was per-
formed with 1:20 dilution of ethanol-precipitated DNA using primers
specific for mouse IL-6 promoter. Densitometric analysis of amplified
PCR products was performed. These results are representative of three
different experiments.
FIG. 8. A–D, TGF-1 inhibits B. vulgatus/LPS-induced recruit-
ment of NF-B to the IL-6 promoter through blockade of histone
acetylation. A, CMT93 cells were stimulated with B. vulgatus lysate
(100 g of protein/ml) and LPS (10 g/ml) for 0–2 h in the presence or
absence of TGF-1 (20 ng/ml). Where indicated cells were pretreated
with trichostatin A (2 h pretreatment with 1 g/ml). Total protein was
extracted, and 20 g of protein was subjected to SDS-PAGE followed by
acetyl-phospho-histone 3 (Lys-9/Ser-10) and -actin immunoblotting
using the ECL technique. B, CMT93 were stimulated with LPS for 16 h
in the presence or absence of TGF-1. Where indicated cells were
pretreated with trichostatin A (2 h pretreatment with 1 g/ml). IL-6
FIG. 9. TGF-1 and Ad5Smad3/Ad5Smad4 inhibits nuclear as-
sociation of CBP/p300 with p65. Where indicated cells were co-
infected with Ad5Smad3/Ad5Smad4 overnight. CMT-93 cells were
stimulated with LPS (10 g/ml) for 30 min in the presence or absence of
TGF-1 (20 ng/ml). Cells were lysed, and the nuclei were pelleted and
resuspended in lysis buffer. Extracts were normalized according to their
protein concentration. Immunoprecipitations (IP) were carried out
overnight using 10 l of anti-NF-B p65 Ab. Immune complexes were
collected with protein A/G-agarose and washed three times in high salt
followed by three washes with no salt buffer. Western blot (WB) anal-
ysis was carried out using anti-CBP/p300 Ab as described under “Ma-
terials and Methods.”
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pathogenic commensal Gram-negative bacteria-induced his-
tone acetylation/phosphorylation and RelA loading to the IL-6
gene promoter in IEC. We suggest that the immunoregulatory
cytokine TGF-1 participates in the maintenance of intestinal
homeostasis by decreasing the ability of commensal luminal
enteric bacteria to activate the NF-B signaling pathway at the
level of gene promoter accessibility.
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